Skip to main content
SpringerLink
Log in

Neurological Aspects of Systemic Lupus Erythematosus in Individuals with Late Ontogenetic Debut

  • Published:
Advances in Gerontology Aims and scope Submit manuscript

Abstract

The review presents the analysis of publications about the peculiarities of the manifestation of systemic lupus erythematosus (SLE) in individuals of older age groups. The probable reasons and mechanisms of the development of neurological manifestations of the disease are reflected in the work. The clinical pattern in elderly patients is described in detail and the peculiarities of immune indices are noted. This article considers different variants of nervous-system damage with SLE that differ in a wide spectrum of clinical manifestations. Neurobehavioral disorders with SLE are one of the least studied aspects and can be both a manifestation of the main disease (including those coinciding with the processes of immunoaging) and adverse events during the treatment. At the same time, knowledge of the peculiarities of neurological manifestations with SLE with its onset in late ontogenesis in comparison with the data of laboratory and instrumental methods of examination allow early diagnosis to be carried out and adequate therapy for elderly patients to be established in a timely manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Belov, B.S., Progressive multifocal leukoencephalopathy: rheumatological aspects, Sovrem. Revmatol., 2015, vol. 9, no. 3, pp. 4–9.

    Article  Google Scholar 

  2. Dil’man, V.M., Chetyre modeli meditsiny (Four Models of Medicine), Leningrad: Meditsina, 1987.

  3. Klyukvina, N.G., Peculiarities of systemic lupus erythematosus with the debut in older adults, Sovrem. Revmatol., 2017, vol. 11, no. 4, pp. 4–11.

    Article  Google Scholar 

  4. Lisitsyna, T.A., Vel’tishchev, D.Yu., Seravina, O.F., et al., Variants of mental disorders in patients with systemic lupus erythematosus, Nauch.-Praktich. Revmatol., 2008, vol. 4, pp. 21–26.

    Google Scholar 

  5. Nasonov, E.L., Antifosfolipidnyi sindrom (Antiphospholipid Syndrome), Moscow: Littera, 2004.

  6. Nasonov, E.L., Rossiiskie klinicheskie rekomendatsii. Revmatologiya (Russian Clinical Recommendations. Rheumatology), Moscow: GEOTAR-Media, 2017.

  7. Nesterov, V.P., Burdygin, A.I., Ivanov, K.B., et al., Peculiarities of autonomous regulation of the cardiovascular system in human late ontogenesis, Usp. Gerontol., 2020, vol. 33, no. 1, pp. 74–80.

    CAS  Google Scholar 

  8. Novitskaya, A.S. and Marusenko, I.M., The nervous system damage in patients with systemic lupus erythematosus, Uchen. Zapiski Petrozavodskogo Gos. Univ., 2010, no. 2, pp. 58–61.

  9. Piven’, V.D., Krasnov, V.S., Novikova, A.S., et al., Neuromyelitis optica spectrum disorder: diagnostics and treatment, experience of clinical observations, Uchen. Zapiski SPbGMU im. akad. I.P. Pavlova, 2018, vol. 25, no. 3, pp. 7–13.

    Google Scholar 

  10. Pizova, N.V., The process of demyelination in systemic rheumatic diseases (literature review), Zh. Nevrol. Psikhiatr., 2012, vol. 9, no. 2, pp. 64–72.

    Google Scholar 

  11. Skoromets, A.A., Somatonevrologiya: Rukovodstvo dlya vrachei (Somatoneurology: Manual for Physicians), St. Petersburg: SpetsLit, 2009, рр. 371–381.

  12. Ainiala, H., Dastidar, P., Loukkola, J., and Lehtimaki, T., Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study, Scand. J. Rheumatol., 2005, vol. 34, no. 5, pp. 376–382.

    Article  CAS  Google Scholar 

  13. Antolin, J., Amerigo, M.J., Cantabrana, A., et al., Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients, J. Clin. Rheumatol., 1995, vol. 14, no. 6, pp. 678–685.

    Article  CAS  Google Scholar 

  14. Appenzeller, S., Pereira, D.A., and Costallat, L.T.L., Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study, Lupus, 2008, vol. 17, no. 11, pp. 1023–1028. https://doi.org/10.1177/0961203308089695

    Article  CAS  Google Scholar 

  15. Arnaud, L., Mathian, A., Boddaert, J., and Amoura, Z., Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment, Drugs Aging, 2012, vol. 29, no. 3, pp. 181–189.

    Article  CAS  Google Scholar 

  16. Asgari, N., Jarius, S., Laustrup, H., et al., Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study, J. Mult. Scler., 2018, vol. 24, no. 3, pp. 331–339.

    Article  Google Scholar 

  17. Baker, S.B., Rovira, J.R., Campion, E.W., and Mills, J.A., Late onset systemic lupus erythematosus, Am. J. Med., 1979, vol. 66, no. 5, pp. 727–732.

    Article  CAS  Google Scholar 

  18. Bertolaccini, M.L., Atsumi, T., Contreras, A.E., et al., The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus, J. Rheumatol., 2001, vol. 28, no. 12, pp. 2637–2643.

    CAS  Google Scholar 

  19. Bertoli, A.M., Alarcon, G.S., Calvo-Alen, J., et al., LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease, J. Arthr. Rheumatol., 2006, vol. 54, no. 5, pp. 1580–1587.

    Article  Google Scholar 

  20. Birnbaum, J., Petri, M., Thompson, R., et al., Distinct subtypes of myelitis in systemic lupus erythematosus, J. Arthr. Rheumatol., 2008, vol. 60, no. 11, pp. 3378–3387.

    Article  Google Scholar 

  21. Boddaert, J., Huong, D.L.T., Amoura, Z., et al., Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in literature, Medicine (Baltimore), 2004, vol. 83, no. 6, pp. 348–359.

    Article  Google Scholar 

  22. Bonfa, E., Steven, M.D., Golomber, J., et al., Association between lupus psychosis and anti-ribosomal P protein antibodies, N. Engl. J. Med., 1987, vol. 317, no. 5, pp. 265–271.

    Article  CAS  Google Scholar 

  23. Bortoluzzi, A., Piga, M., Silvagni, E., et al., Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome, Lupus, 2019, vol. 28, no. 4, pp. 465–474. https://doi.org/10.1177/0961203319828499

    Article  CAS  Google Scholar 

  24. Cervera, R., Khamashta, M.A., Font, J., et al., Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic lupus erythematosus, Medicine (Baltimore), 1993, vol. 72, no. 2, pp. 113–124.

    Article  CAS  Google Scholar 

  25. Chen, T.-L., Wong, C.-H., Lee, C.-S., et al., Systemic lupus erythematosus in the elderly, Int. J. Geront., 2009, vol. 3, no. 2, pp. 108–113.

    Article  Google Scholar 

  26. Cohen, H., Rijnink, E.C., Nabuurs, R.J.A., et al., Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement, Rheumatology (Oxford), 2016, vol. 56, no. 1, pp. 77–86.

    Article  Google Scholar 

  27. Cui, H.-W., Lei, R.-Y., Zhang, S.-G., et al., Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study, Lupus, 2019, vol. 28, no. 8, pp. 961–969. https://doi.org/10.1177/0961203319856416

    Article  Google Scholar 

  28. Damrongpipatkul, U., Oranratanachai, K., Kasitanon, N., et al., Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study, J. Clin. Rheumatol., 2018, vol. 37, no. 7, pp. 691–702.

    Article  Google Scholar 

  29. Denburg, S.D. and Denburg, J.A., Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus, Lupus, 2003, vol. 12, no. 12, pp. 883–890. https://doi.org/10.1191/0961203303lu497oa

    Article  CAS  Google Scholar 

  30. Dimant, J., Ginzler, E.M., Schlesinger, M., et al., Systemic lupus erythematosus in the older age group: computer analysis, J. Amer. Geriatr. Soc., 1979, vol. 27, no. 2, pp. 58–61.

    Article  CAS  Google Scholar 

  31. Domenech, I., Aydintug, O., Cervera, R., et al., Systemic lupus erythematosus in 50 year olds, J. Postgrad. Med., 1992, vol. 68, no. 800, pp. 440–444.

    Article  CAS  Google Scholar 

  32. Ellie, M. and Wekking, M.A., Psychiatric symptoms in systemic lupus erythematosus: an update, J. Psychosom. Med., 1993, vol. 55, no. 2, pp. 219–228.

    Article  Google Scholar 

  33. Ercan, E., Ingo, C., Tritanon, O., et al., A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus, J. Neuroimage Clin., 2015, vol. 8, pp. 337–344.

    Article  Google Scholar 

  34. Font, J., Pallares, L., Cervera, R., et al., Systemic lupus erythematosus in the elderly: clinical and immunological characteristics, J. Ann. Rheumatol. Dis., 1991, vol. 50, pp. 702–705.

    Article  CAS  Google Scholar 

  35. Gossat, D.M. and Walls, R.S., Systemic lupus erythematosus in later life, Med. J. Australia, 1982, vol. 1, pp. 297–299.

    Article  CAS  Google Scholar 

  36. Graham, R.R., Ortmann, W., Rodine, P., et al., Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE, Europ. J. Hum. Genet., 2007, vol. 15, no. 8, pp. 823–830.

    Article  CAS  Google Scholar 

  37. Hanly, J.G., McCurdy, G., Fougere, L., et al., Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance, J. Rheum., 2004, vol. 31, no. 11, pp. 2056–2062.

    Google Scholar 

  38. Henegar, C.E., Eudy, A.M., Kharat, V., et al., Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review, Lupus, 2016, vol. 25, no. 6, pp. 617–626. https://doi.org/10.1177/0961203315622819

    Article  CAS  Google Scholar 

  39. Ho, C.T., Mok, C.C., Lau, C.S., and Wong, R.W., Late onset systemic lupus erythematosus in southern Chinese, J. Ann. Rheumatol. Dis., 1998, vol. 57, no. 7, pp. 437–440.

    Article  CAS  Google Scholar 

  40. Ho, R.C., Thiaghu, C., Ong, H., et al., A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus, J. Autoimmunol. Rev., 2016, vol. 15, no. 2, pp. 124–138.

    Article  CAS  Google Scholar 

  41. Huang, X.Y., Magder, L.S., and Petri, M., Predictors of incident seizure in systemic lupus erythematosus, J. Rheumatol., 2016, vol. 43, no. 3, pp. 565–575.

    Article  CAS  Google Scholar 

  42. Kampylafka, E.I., Alexopoulos, H., Kosmidis, M.L., et al., Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients, PLoS One, 2013, vol. 8, no. 2. https://doi.org/10.1371/journal.pone.0055843

  43. Kovacs, B., Lafferty, T.L., Brent, L.H., et al., Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature, Ann. Rheumatol. Dis., 2000, vol. 59, pp. 120–124.

    Article  CAS  Google Scholar 

  44. Khalili, A. and Kuper, R.C., A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE), J. Clin. Exp. Immunol., 1991, vol. 85, no. 3, pp. 365–372.

    Article  CAS  Google Scholar 

  45. Kuo, C.-F., Grainge, M.J., Valdes, A.M., et al., Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families, J.A.M.A. Intern. Med., 2015, vol. 175, no. 9, pp. 1518–1526. https://doi.org/10.1001/jamainternmed.2015.3528

    Article  Google Scholar 

  46. Lalani, S., Pope, J., de Leon, F., and Peschken, C., Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study, J. Rheumatol., 2010, vol. 37, no. 1, pp. 38–44.

    Article  Google Scholar 

  47. Lazaro, D., Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment, J. Drugs Aging, 2007, vol. 24, no. 9, pp. 701–715.

    Article  CAS  Google Scholar 

  48. Legriel, S., Pico, F., and Azoulay, E., Understanding posterior reversible encephalopathy syndrome, Ann. Update Intens. Care Emergency Med., 2011, pp. 631–653. https://doi.org/10.1007/978-3-642-18081-156

  49. Luyendijk, J., Steens, S.C.A., Ouwendijk, W.J.N., et al., Neuropsychiatric systemic lupus erythematosus, J. Arthr. Rheumatol., 2011, vol. 63, no. 3, pp. 722–732.

    Article  CAS  Google Scholar 

  50. Medin, J.L., Hansen, K.E., Fitz, S.R., and Bartels, C.M., A systematic review and metaanalysis of cutaneous manifestations in late versus early-onset systemic lupus erythematosus, Seminars Arthr. Rheumatol., 2016, vol. 45, no. 6, pp. 691–697. https://doi.org/10.1016/j.semarthrit.2016.01.004

    Article  Google Scholar 

  51. Mirsattari, S.M., Power, C., Fine, A., and McGinn, G.S., Neuropsychiatric systemic lupus erythematosus and the syndrome of inappropriate secretion of antidiuretic hormone: a case report with very late onset systemic lupus erythematosus, Brit. J. Rheumatol., 1998, vol. 37, no. 10, pp. 1132–1134.

    Article  CAS  Google Scholar 

  52. Mikdashi, J., Kennedy, S., and Krumholz, A., Recurrent benign lymphocytic (Mollaret) meningitis in systemic lupus erythematosus, J. Neurol., 2008, vol. 14, no. 1, pp. 43–45.

    Google Scholar 

  53. Mol, C.C., Lau, C.S., Lee, K.W., and Wong, R.W., Hyperprolactinemia in males with systemic lupus erythematosus, J. Rheumatol., 1998, vol. 25, no. 12, pp. 2357–2363.

    Google Scholar 

  54. Mantovani, C., Louzada-Junior, P., Nunes, E.A., et al., Antinuclear antibodies testing as a routine screening for systemic lupus erythematosus in patients presenting first-episode psychosis, Early Interv. Psychiatr., 2012, vol. 6, no. 3, pp. 322–325. https://doi.org/10.1111/j.1751-7893.2011.00339.x

    Article  Google Scholar 

  55. Moyssakis, I., Tektonidou, M.G., Vasilliou, V.A., et al., Libman-sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution, Am. J. Med., 2009, vol. 120, no. 7, pp. 636–642.

    Article  Google Scholar 

  56. Nikolopoulos, D., Kostopoulou, M., Pieta, A., et al., Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the “Attikon” cohort, Lupus, 2020, vol. 29, no. 5, pp. 514–522. https://doi.org/10.1177/0961203320908932

    Article  CAS  Google Scholar 

  57. Penaranda-Parada, E., Quintana, G., Yunis, J.J., et al., Clinical, serologic and immunogenetic characterization (HLA-DRB1) of late-onset lupus erythematosus in a Colombian population, Lupus, 2015, vol. 24, no. 12, pp. 1293–1299. https://doi.org/10.1177/0961203315588576

    Article  CAS  Google Scholar 

  58. Piga, M., Chessa, E., Peltz, M.T., et al., Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis, Autoimmunol. Rev., 2017, vol. 16, no. 3, pp. 244–252. https://doi.org/10.1016/j.autrev.2017.01.011

    Article  Google Scholar 

  59. Pirro, F., Mantero, V., Rigamonti, A., et al., A case of longitudinally extensive transverse myelitis in an 80-year-old patient with systemic lupus erythematous and anti-aquaporin 4 antibodies, J. Mult. Scler. Relat. Disord., 2021. https://doi.org/10.1016/j.msard.2021.102899

  60. Richards, A.J., Hydroxychloroquine myopathy, J. Rheum., 1998, vol. 25, no. 8, pp. 1642–1643.

    CAS  Google Scholar 

  61. Rose, E. and Pillsbury, D., Lupus erythematosus (erythematodes) and ovarian function: observations on a possible relationship, with report of six cases, Ann. Intern. Med., 1944, vol. 21, no. 6, pp. 1022–1034.

    Article  Google Scholar 

  62. Scolding, N.J. and Joseph, F.G., The neuropathology and pathogenesis of systemic lupus erythematosus, Neuropathol. Appl. Neurobiol., 2002, vol. 28, no. 3, pp. 173–189.

    Article  CAS  Google Scholar 

  63. Shaban, A. and Leira, E.C., Neurological complications in patients with systemic lupus erythematosus, Curr. Neurol. Neurosci. Rep., 2019, vol. 19, no. 12, pp. 1–10. https://doi.org/10.1007/s11910-019-1012-1

    Article  Google Scholar 

  64. Stefanidou, S., Gerodimos, C., Benos, A., et al., Clinical expression and course in patients with late onset systemic lupus erythematosus, Hippokratia, 2013, vol. 17, no. 2, pp. 153–156.

    CAS  Google Scholar 

  65. Sun, K.H., Liu, W.T., Tsai, C.Y., et al., Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum, J. Ann. Rheumatol. Dis., 1992, vol. 51, no. 6, pp. 707–712.

    Article  CAS  Google Scholar 

  66. Tan, E.K., Chan, L.L., and Auchus, A.P., Reversible parkinsonism in systemic lupus erythematosus, J. Neurol. Sci., 2001, vol. 193, no. 1, pp. 53–57.

    Article  CAS  Google Scholar 

  67. Tomic-Lucic, A., Petrovic, R., Radak-Perovic, M., et al., Late-onset systemic lupus erythematosus: clinical features, course and prognosis, J. Clin. Rheumatol., 2013, vol. 32, no. 7, pp. 1053–1058.

    Article  Google Scholar 

  68. Tzioufas, A.G., Tzortzakis, N.G., Panou-Pomonis, E., et al., The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease, J. Ann. Rheumatol. Dis., 2000, vol. 59, no. 2, pp. 99–104.

    Article  CAS  Google Scholar 

  69. Wang, L., Chen, H., Zhang, Y., et al., Clinical characteristics of cerebral venous sinus thrombosis in patients with systemic lupus erythematosus: a single-centre experience in China, J. Immunol. Res., 2015. https://doi.org/10.1155/2015/540738

  70. van den Hoogen, L.L., Sims, G.P., van Roon, J.A.G., and Fritsch-Stork, R.D.E., Aging and systemic lupus erythematosus—immunosenescence and beyond, Curr. Aging Sci., 2015, vol. 8, no. 2, pp. 158–177.

    Article  CAS  Google Scholar 

  71. Wilson, H.A., Hamilton, M.E., Spykek, D.A., et al., Age influences the clinical and serologic expression of systemic lupus erythematosus, J. Arthr. Rheumatol., 1981, vol. 24, no. 10, pp. 1230–1235.

    Article  CAS  Google Scholar 

  72. Xianbin, W., Mingyu, W., Dong, X., et al., Peripheral neuropathies due to systemic lupus erythematosus in China, Medicine (Baltimore), 2015, vol. 94, no. 11. https://doi.org/10.1097/MD.0000000000000625

Download references

Author information

Authors and Affiliations

  1. Kirov Military Medical Academy, 194044, St. Petersburg, Russia

    V. I. Odin, A. K. Yurkin & M. M. Toporkov

  2. Mechnikov North-Western State Medical University, 191015, St. Petersburg, Russia

    E. A. Yurkina, G. I. Shvartsman & E. M. Pervova

Authors
  1. V. I. Odin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. A. Yurkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. K. Yurkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. M. Toporkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. I. Shvartsman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. M. Pervova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. I. Odin.

Ethics declarations

Conflict of Interests. We declare that we have no conflicts of interest.

Statement of Compliance with Standards of Research involving Humans as Subjects. This article does not contain any studies involving human participants performed by any of the authors.

Additional information

Translated by A. Barkhash

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Odin, V.I., Yurkina, E.A., Yurkin, A.K. et al. Neurological Aspects of Systemic Lupus Erythematosus in Individuals with Late Ontogenetic Debut. Adv Gerontol 12, 396–406 (2022). https://doi.org/10.1134/S2079057022040129

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079057022040129

Keywords:

Search

Navigation